Feb 27, 2015 9:00 am EST Capricor Therapeutics Appoints Thomas Copmann, Ph.D. as Vice President of Regulatory Affairs and Drug Development
Feb 04, 2015 9:00 am EST Capricor Therapeutics Announces $7 Million Private Placement of Common Stock
Jan 21, 2015 8:00 am EST Capricor Therapeutics and CureDuchenne to Host Webinar on January 21, 2015 at 3:00 p.m. ET
Jan 12, 2015 12:32 pm EST Capricor Therapeutics Initiates the DYNAMIC Clinical Trial for the Treatment of Advanced Heart Failure
Jan 12, 2015 9:26 am EST Capricor Therapeutics Announces $10 Million Private Placement of Common Stock
Dec 02, 2014 7:45 am EST Capricor Therapeutics Announces Linda Marban, Ph.D. Will Present a Company Overview and Serve as an Expert Panelist at Piper Jaffray's 26th Annual Healthcare Conference
Nov 18, 2014 7:45 am EST Capricor Therapeutics Announces Positive Pre-Clinical Data for Cardiosphere-Derived Cells (CDCs) on Duchenne Muscular Dystrophy Cardiomyopathy
Nov 12, 2014 8:30 am EST Capricor Therapeutics Reports Third Quarter 2014 Financial & Business Highlights